Introduction
CT is the cornerstone for evaluating interstitial lung disease pulmonary nodules and thoracic malignancy while MRI provides complementary soft tissue and vascular assessment. High resolution CT protocols and standardized reporting improve diagnostic accuracy. Multimodality imaging supports staging and treatment planning.
Interstitial Lung Disease
High resolution CT with thin slices and inspiratory expiratory phases characterizes patterns of fibrosis and guides multidisciplinary diagnosis. Quantitative CT metrics and serial imaging monitor progression and response to therapy. Correlation with pulmonary function tests and clinical history is essential.
Nodule Evaluation and Oncology
Low dose CT screening detects pulmonary nodules and follow up protocols use size and growth criteria to guide management. PET CT provides metabolic assessment for staging and characterization of indeterminate nodules. MRI is useful for chest wall mediastinal and cardiac invasion assessment in thoracic oncology.
Reporting and Multidisciplinary Care
Standardized reporting systems and multidisciplinary thoracic oncology boards improve staging and treatment decisions. Imaging guides biopsy planning surgical resection and radiation therapy. Close collaboration with pulmonology and oncology ensures integrated care.